This trial started in 2014 and these results were published in 2016. Researchers wanted to find out whether nivolumab helped people with Hodgkin lymphoma that had come back after a stem cell ...

Non-Hodgkin Lymphoma Perspective Are We on the Brink of Redefining Follicular Lymphoma? A young specialist explores a paradigm shift in the cyclical 'treat, respond, relapse, ...

At the second attempt, the FDA has approved Citius Pharmaceuticals' Lymphir for rare lymphoma CTCL ... resurrecting the use of IL-2-directed therapy for this rare form of non-Hodgkin lymphoma ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated diffuse large B-cell lymphoma (DLBCL), cementing the antibody-drug conjugate ...

You look in the mirror and see a spot. It wasn’t there just yesterday, maybe. Sometimes we poke or try to squeeze it. But ...

News about Vladimir Putin, including commentary and archival articles published in The New York Times.

Innovation in the pharmaceutical industry has been limited for a long time to the research and development of new active compounds; meanwhile, the structure of the production, dominated by batchwise ...